Noninvasive Artificial Venous Stasis for Reperfusion in STEMI
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFirat University
About this trial
This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.
Eligibility criteria
Qualifiers
Having presented within the first 12 hours of symptom onset Being hemodynamically stable (Killip Class I-II)
STEMI diagnosis confirmed by coronary angiography
Primary PCI (percutaneous coronary intervention) scheduled
No pathology in the upper extremity that would prevent cuff application
Disqualifiers
Presence of cardiogenic shock (systolic blood pressure < 90 mmHg and Killip Class III-IV)
Cardiac arrest occurring before or after the procedure
Need for resuscitation following failed thrombolysis
History of prior coronary artery bypass surgery
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov